Venture Capital


Investment in UK biotech sector up 60% in 2021

By Rachel Arthur

Last year was the highest year on record for investments into UK biotech and life science companies: with £4.5bn ($6bn) raised in public and private financings, representing 60% more than in 2020.

© GettyImages/champc

October sees boost for biotech funding

By Jane Byrne

Biotech funding kicked back into higher gear in October, pushing toward the summer monthly record highs with $10.5B raised, writes analyst firm, Jefferies

© GettyImages/AndreyPopov

Disruptor in cell and gene therapy space secures US$30m in funding

By Jane Byrne

Ori Biotech Ltd (Ori), a London and New Jersey based innovator in the cell and gene therapy (CGT) manufacturing sphere, last week announced the successful close of a US$30m Series A financing round, bringing the company’s total funding to date to US$41m.

Architects' plans for the Nottingham, UK facility

$47m innovation facility built in Nottingham, UK

By Fiona BARRY

The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture capital fund which will invest in the SME tenants.